Trial intelligence / Profile preview

Fuqi Guben Paste for Nocturia due to Kidney Yang Deficiency

CTR20213298Phase 2Completed

Sponsor
Yunnan Institute of Materia Medica
Start
Dec 2021
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Fuqiguben Paste in nocturia, Kidney Yang Deficiency (KYD), sponsored by Yunnan Institute of Materia Medica. Started Dec 2021; status: completed.

02

Drugs

Fuqiguben Paste
03

Conditions

nocturiaKidney Yang Deficiency (KYD)

Beyond the preview

Go deeper on CTR20213298.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20213298.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call